Patent ID: 8203001
Filing Date: 2012-06-19
Classification: A61P,C07D

Abstract:
1. A compound of formula (1C) R each R each R each R each R each R each R each R each R each R optionally in the form of tautomers, racemates, enantiomers, diastereomers and mixtures thereof, and optionally pharmacologically acceptable salts thereof, with the provisos that neither R the compounds [6-(carboxymethyl-amino)-benzo[1,2-d;5,4-d]bisthiazol-2-ylamino]-acetic acid, 2-[6-(diethylcarbamoylmethyl-amino)-benzo[1,2-d;5,4-d]bisthiazol-2-ylamino]-N,N-diethyl-acetamide, ethyl [6-(ethoxycarbonylmethyl-amino)-benzo[1,2-d;5,4-d]bisthiazol-2-ylamino]-acetate, N,N′-bis-(2-diethylamino-ethyl)-benzo[1,2-d;5,4-d]bisthiazole-2,6-diamine, N,N′-bis-(4-diethylamino-1-methyl-butyl)-benzo[1,2-d;5,4-d]bisthiazole-2,6-diamine, N,N′-dimethyl-benzo[1,2-d;5,4-d]bisthiazole-2,6-diamine, N,N′-diethyl-benzo[1,2-d;5,4-d]bisthiazole-2,6-diamine, 4-bromo-N,N′-diethyl-benzo[1,2-d;5,4-d]bisthiazole-2,6-diamine, 4,N,N′-trimethyl-benzo[1,2-d;5,4-d]bisthiazole-2,6-diamine, N,N,N′,N′-tetramethyl-benzo[1,2-d;5,4-d]bisthiazole-2,6-diamine, N,N′-dipropyl-benzo[1,2-d;5,4-d]bisthiazole-2,6-diamine, N,N′-diisopropyl-benzo[1,2-d;5,4-d]bisthiazole-2,6-diamine, N,N,N′,N′-tetraethyl-benzo[1,2-d;5,4-d]bisthiazole-2,6-diamine and N,N′-diethyl-N,N′-dimethyl-benzo[1,2-d;5,4-d]bisthiazole-2,6-diamine are excluded.